Weight Loss Drugs Changed Their Lives. Then They Lost Coverage.
The letter came in June. Mindy McCormick, 67, read that her insurer would soon stop covering the weight loss drug Wegovy, which she had been taking for more than two years. What? she remembers thinking.
Opinion
The half promise of weight-loss drugs
Groundbreaking weight-loss drugs like Ozempic and Wegovy have understandably generated a lot of excitement, bringing hope to the hundreds of millions of people grappling
Weight loss drugs help with fat loss – but they cause bone and muscle loss too
Up to a third of the weight lost while taking weight loss jabs such as Wegovy and Mounjaro includes muscle and bone mass.
Opinion
Opinion: Weight-loss drugs are great, but real food still matters
Groundbreaking weight-loss drugs like Ozempic and Wegovy have understandably generated a lot of excitement, bringing hope to the hundreds of millions of people grappling with obesity. When combined with a healthier diet and exercise,
What's ahead for weight loss drugs in 2025, according to Noom's CEO
Quartz spoke with Noom CEO Geoff Cook to get his take on what 2025 holds for the compounded drug market and the overall future of weight-loss drugs. Cook took over as CEO of the psychology-based weight loss app Noom in 2023,
Weight-loss drugs draw Americans back to the doctor
Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with obesity-related conditions or take the drugs to become eligible for other services,
Pricey weight loss drugs lose some disciples in 2024
People struggling with their body weight experienced joy when new, more effective prescription drug options became the rage in 2023, but it seems many folks stopped taking them in 2024.
Holidays on weight-loss drugs: A relief for some, 'sad' and difficult for others
Part of the joy of the season may be gone — or feel different — for people who are taking popular weight-loss drugs and can't eat as much as before.
Weight loss drugs could help end obesity - but risks remain, WHO says
A new class of weight loss drugs developed by Novo Nordisk and Eli Lilly “opens the possibility of an end to the obesity pandemic” alongside other interventions, the World Health Organization (WHO) said this week.
Lilly Weight-Loss Drug Shortage in US Has Ended, FDA Says
Eli Lilly & Co.’s weight-loss and diabetes drugs Mounjaro and Zepbound are no longer in short supply in the US, which means compounding pharmacies must stop making copycats in the coming months.
UK Woman's Death After Using Weight Loss Drugs Raises Questions On Its Safety
Are approved weight loss drugs unsafe? A UK woman and a Scottish nurse's death linked with popular weight loss drugs, raises questions on its safety? FDA has also issued warning.
MIT Technology Review2d
The Download: shaking up neural networks, and the rise of weight-loss drugs
Scientists have known for years that light pollution is growing and can harm both humans and wildlife. In people, increased ...
‘Mrs. Doubtfire’ actor Harvey Fierstein reveals he dropped 120 pounds with weight-loss drug
What’s different is what the drug actually does for you which is I don’t feel like I’m dieting,” he explained. “I feel like a ...
FOX13 Memphis10d
Illegal black market weight loss drugs sold out of Mid-South home and clinics, drug task force says
The woman selling the illegal black market weight loss drugs not only sold them out of her home, but supplied the drugs to ...
Novo Nordisk stock plunges 20% after a trial of its latest weight loss drug disappoints
The Ozempic maker's stock tanked after its highly anticipated CagriSema drug trial showed an average of 22.7% weight loss, ...
An experimental drug drove people to lose 23% of their body weight. It’s still seen as a disappointment
Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...
In weight loss battle, Novo and Lilly face growing offensive from licensed copies
As Novo Nordisk and Eli Lilly expand sales of their popular diabetes and weight-loss drugs, cheaper copies of their patented ...